Impact of epidermal growth factor receptor (EGFR) mutations on responsiveness of non-small cell lung cancer (NSCLC) to tyrosine kinase inhibitors (TKIS): Prospective observations

被引：1
|
作者：
van Zandwijk, Nico
Mathy, Alexandre
de Jong, Daphne
Baas, Paul
Burgers, Sjaak
Nederlof, Petra
机构：
[1] Netherlands Canc Inst, Dept Thorac Oncol, Amsterdam, Netherlands
[2] Netherlands Canc Inst, Dept Mol Pathol, Amsterdam, Netherlands
来源：
EJC SUPPLEMENTS | 2006年 / 4卷 / 06期
关键词：
D O I：
10.1016/j.ejcsup.2006.04.030
中图分类号：
R73 [肿瘤学];
学科分类号：
100214 ;
摘要：
S29
引用
下载
收藏
页码：14 / 15
页数：2
相关论文
共 50 条
  • [1] Epidermal growth factor receptor tyrosine kinase inhibitors (EGFR-TKIs) impact on immune microenvironment in non-small cell lung cancer (NSCLC).
    Tang, Jie
    Liu, XiaoLing
    Gong, Youling
    Zhu, Jiang
    Huang, Meijuan
    Ding, Zhenyu
    Yu, Min
    Tie, Yan
    Li, Qiu
    Wang, Yongsheng
    [J]. JOURNAL OF CLINICAL ONCOLOGY, 2018, 36 (15)
  • [2] EPIDERMAL GROWTH FACTOR RECEPTOR (EGFR) CO-MUTATED ADVANCED NON-SMALL CELL LUNG CANCER (NSCLC) AND RESPONSE TO EGFR TYROSINE KINASE INHIBITORS (TKIS)
    Barnet, Megan B.
    O'Toole, Sandra
    Horvath, Lisa' G.
    Selinger, Christina
    Yu, Bing
    Trent, Ronald
    Ng, Chiu Chin
    Boyer, Michael J.
    Cooper, Wendy
    Kao, Steven
    [J]. ASIA-PACIFIC JOURNAL OF CLINICAL ONCOLOGY, 2014, 10 : 156 - 156
  • [3] Optimizing the sequencing of tyrosine kinase inhibitors (TKIs) in epidermal growth factor receptor (EGFR) mutation-positive non-small cell lung cancer (NSCLC)
    Gelatti, Ana C. Z.
    Drilon, Alexander
    Santini, Fernando C.
    [J]. LUNG CANCER, 2019, 137 : 113 - 122
  • [4] Rebiopsy of patients with "acquired resistance" to epidermal growth factor receptor tyrosine kinase inhibitors (EGFR-TKIs) in non-small cell lung cancer (NSCLC)
    Miller, Vincent A.
    Riely, Gregory J.
    Arcila, Maria E.
    Oxnard, Geoffrey
    Zakowski, Maureen F.
    Kris, Mark G.
    Pao, William
    Ladanyi, Marc
    [J]. JOURNAL OF THORACIC ONCOLOGY, 2009, 4 (09) : S314 - S314
  • [5] Tyrosine Kinase Inhibitors and Epidermal Growth Factor Receptor (EGFR) Mutations in Non-Small Cell Lung Cancer To Test or Not to Test?
    Gazdar, Adi F.
    [J]. MEDICINE, 2011, 90 (03) : 168 - 170
  • [6] Adjuvant epidermal growth factor receptor tyrosine kinase inhibitors (EGFR TKIs) for non-small cell lung cancer (NSCLC): A systematic review and meta-analysis
    Raphael, J.
    Vincent, M.
    Boldt, G.
    Shah, P.
    Rodrigues, G.
    Blanchette, P.
    [J]. JOURNAL OF THORACIC ONCOLOGY, 2018, 13 (04) : S77 - S77
  • [7] Treatment of brain metastases in non-small cell lung cancer (NSCLC) patients with epidermal growth factor receptor (EGFR) mutations: the role of EGFR tyrosine kinase inhibitors
    Karachaliou, Niki
    Rosell, Rafael
    [J]. ANNALS OF PALLIATIVE MEDICINE, 2013, 2 (03) : 114 - 117
  • [8] Small molecule epidermal growth factor receptor (EGFR) tyrosine kinase inhibitors in non-small cell lung cancer
    Cascone, T
    Morelli, MP
    Ciardiello, F
    [J]. ANNALS OF ONCOLOGY, 2006, 17 : 46 - 48
  • [9] Tumor heterogeneity affects the activity of epidermal growth factor receptor (EGFR) tyrosine kinase inhibitors (TKIs) in EGFR mutant non-small cell lung cancer (NSCLC) patients (pts)
    Normanno, N.
    Rachiglio, A. M.
    Lambiase, M.
    Fenizia, F.
    Iannaccone, A.
    Chicchinelli, N.
    Morabito, A.
    Montanino, A.
    Rocco, G.
    Galetta, D.
    Montagna, S.
    Crino, L.
    Ludovini, V.
    Vincenzi, B.
    Barletta, E.
    Pinto, C.
    Ferrau, F.
    Botti, G.
    Piccirillo, M. C.
    Perrone, F.
    [J]. ANNALS OF ONCOLOGY, 2016, 27
  • [10] Tumor heterogeneity affects the activity of epidermal growth factor receptor (EGFR) tyrosine kinase inhibitors (TKIs) in EGFR mutant non-small cell lung cancer (NSCLC) patients (pts)
    Normanno, N.
    Rachiglio, A. M.
    Lambiase, M.
    Fenizia, F.
    Iannaccone, A.
    Chicchinelli, N.
    Morabito, A.
    Rocco, G.
    Galetta, D.
    Montagna, E. S.
    Crino, L.
    Ludovini, V.
    Vincenzi, B.
    Barletta, E.
    Pinto, C.
    Ferrau, F.
    Botti, G.
    Piccirillo, C.
    Perrone, F.
    [J]. ANNALS OF ONCOLOGY, 2016, 27
12345